Furthermore, TPEN, a membrane-permeable zinc chelator, was found to reduce Zn2+ accumulation in cerebral ischemia animal models by inhibiting PARP-1 activation (Zhao et al. 2014). This evidence concerns the gene PARP1 and brain ischemia.